1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsTwo separate prizes awarded in 2026: one for immunodeficiency projects, one for immune-mediated neuropathies research. Applications evaluated by independent European expert committees.
LFB Research Grant in Immunology 2026 is sponsored by LFB Corporate. This initiative aims to encourage health professionals to submit work to improve the management of patients treated with immunoglobulins and their quality of life.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
LFB Grants - LFB Corporate LFB confirms its commitment to research for the benefit of patients by launching the new edition of “LFB Research Grant in Immunology. ” This initiative unveiled by LFB aims to encourage health professionals to submit work to improve the management of patients treated with immunoglobulins and their quality of life.
Two prizes will be awarded in 2026 as part of the LFB Research Grant in Immunology and will be for: A project in the field of immunodeficiencies , A project in the field of immune-mediated neuropathies . The amount of each prize is €20,000.
The LFB Research Grant in Immunology 2026 is reserved for healthcare professionals from Austria, Belgium, France, Germany, Greece, Italy, Mexico, Spain, The Netherlands, Turkey, and the United Kingdom. For each prize, applications will be reviewed by an independent committee of recognized European experts.
Committee for projects related to immunodeficiency : Prof. Javier Carbon, Spain Prof. Francisco Espinoza Rosales, Mexico Dr. Nizar Mahlaoui, France Prof. Stephen Jolles, United Kingdom Dr. Med. Leif Hanitsch, Germany Committee for projects related to immune-mediated neuropathies : Prof. Helmar Lehmann, Germany Prof. Yesim Parman, Turquey Prof. Yusuf A.
Rajabally, United Kingdom Prof. Shahram Attarian, France Prof. Steven Vargas, Mexico The deadline for submission of applications is October 31 st , 2026 . Detailed information on eligibility criteria and application files:
According to the current listing, eligibility includes: Healthcare professionals from Austria, Belgium, France, Germany, Greece, Italy, Mexico, Spain, The Netherlands, Turkey, and the United Kingdom. Confirm the full requirements in the official notice before applying.
The current listing shows €20,000 (two prizes). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for LFB Research Grant in Immunology 2026 are due October 31, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
LFB Research Grant in Immunology 2026 is funded by LFB Corporate. Verify program details on the funder's official page before applying.
This listing is flagged as international in scope. Check the official notice for country-specific restrictions before applying.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
The Humana Foundation's first 2026 slate funded 13 nonprofits and five university research teams around senior and veteran emotional health, with awards from $150,000 to $3 million concentrated in Texas, Florida, and Kentucky. A second health equity slate is planned for fall 2026. Here is what the portfolio structure reveals about how this funder decides, and how aging-services and behavioral health organizations should position.
Read articleEffective January 1, 2026, the One Big Beautiful Bill Act fundamentally restructured the charitable deduction. Individual itemizers now lose the first 0.5% of AGI before any deduction; corporations lose the first 1% of taxable income; top-bracket donors are capped at a 35% effective deduction rate; and the 86% of taxpayers who do not itemize finally have an above-the-line deduction of up to $1,000 ($2,000 joint). EY projects $4.4-4.8B in annual corporate giving losses. Fundraisers who do not segment their donor communications by floor exposure this year will lose six-figure gifts to timing arbitrage.
Read articleCompare Google, Microsoft, Meta, and NVIDIA research grants against NSF, DARPA, DOE, and NIH federal funding for AI research.
Read article